Literature DB >> 14659851

Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese.

Takefumi Nojiri1, Hiroyuki Morita, Yasushi Imai, Koji Maemura, Minoru Ohno, Ken Ogasawara, Tadanori Aizawa, Akira Saito, Doubun Hayashi, Yasunobu Hirata, Takao Sugiyama, Tsutomu Yamazaki, Ryozo Nagai.   

Abstract

Matrix metalloproteinases (MMPs) are involved in plaque rupture, which is the main pathological cause of myocardial infarction (MI). Recently, several genetic studies have demonstrated that MMP-1 1G/2G polymorphism and MMP-3 5A/6A polymorphism modify each transcriptional activity in allele specific manners. Within this context, we conducted case-control studies to examine whether these genetic polymorphisms are associated with susceptibility to MI. Two groups comprising patients with MI (group-1 164 patients, group-2 302 patients) were compared with control group comprising 335 patients without cardiovascular diseases. The MMP-3 5A allele was more frequent in patients with MI than in the control subjects (P=0.018 MI group-1, P=0.0059 MI group-2), whereas there was no disease association for MMP-1 genotypes. Logistic regression analyses revealed that MMP-3 5A/6A polymorphism was associated with susceptibility to MI [odds ratio(OR) (95% confidential interval) 1.67 (1.02-2.74); P=0.042, MI group-1; 1.61 (1.12-2.23); P=0.0095, MI group-2]. Other important findings were that there was strong linkage disequilibrium between these polymorphisms, which are located closely on chromosome 11q.22, and that the 5A-1G haplotype was a genetic risk factor for MI (OR 1.97 P=0.0082, MI group-1 OR 1.51 P=0.017, MI group-2). Taken together, the present findings suggest that genetic variations in these MMP genes and especially their haplotype may be useful genetic markers for determining susceptibility to MI in Japanese.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14659851     DOI: 10.1016/s0167-5273(03)00100-1

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  17 in total

1.  Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.

Authors:  Richard Sherva; Charles E Ford; John H Eckfeldt; Barry R Davis; Eric Boerwinkle; Donna K Arnett
Journal:  Stroke       Date:  2010-12-23       Impact factor: 7.914

2.  Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.

Authors:  Benjamin D Horne; Nicola J Camp; John F Carlquist; Joseph B Muhlestein; Matthew J Kolek; Zachary P Nicholas; Jeffrey L Anderson
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

3.  The Role of Matrix Metalloproteinase-3 In the Development of Atherosclerosis and Cardiovascular Events.

Authors:  Krintus Magdalena; Kuligowska Magdalena; Sypniewska Grazyna
Journal:  EJIFCC       Date:  2006-03-20

Review 4.  The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis.

Authors:  Sonia Abilleira; Steve Bevan; Hugh S Markus
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

5.  Risk of coronary artery stenosis in Iranian type 2 diabetics: is there a role for matrix metalloproteinase-3 gene (-1612 5A/6A) polymorphism?

Authors:  Soudabeh Fallah; Morteza Seifi; Ali Samadikuchaksaraei
Journal:  J Physiol Biochem       Date:  2010-08-26       Impact factor: 4.158

6.  Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population.

Authors:  Kavita K Shalia; V K Shah; M R Mashru; S L Soneji; J B Vasvani; S Payannavar; A Walvalkar; R Mokal; S S Mithbawkar; M Bootwalla; P Sadvekar; P K Thakur
Journal:  Indian J Clin Biochem       Date:  2010-05-27

7.  MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study.

Authors:  Kelly A Volcik; Stephen Campbell; Lloyd E Chambless; Josef Coresh; Aaron R Folsom; Thomas H Mosley; Hanyu Ni; Lynne E Wagenknecht; Bruce A Wasserman; Eric Boerwinkle
Journal:  Atherosclerosis       Date:  2009-12-11       Impact factor: 5.162

Review 8.  Matrix metalloproteinases and myocardial infarction.

Authors:  Wannakorn Phatharajaree; Arintaya Phrommintikul; Nipon Chattipakorn
Journal:  Can J Cardiol       Date:  2007-07       Impact factor: 5.223

9.  Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels.

Authors:  Yu-Ching Cheng; Wen-Hong L Kao; Braxton D Mitchell; Jeffrey R O'Connell; Haiqing Shen; Patrick F McArdle; Quince Gibson; Kathleen A Ryan; Alan R Shuldiner; Toni I Pollin
Journal:  Circ Cardiovasc Genet       Date:  2009-05-14

10.  Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesity.

Authors:  Hsuan-Li Huang; Semon Wu; Lung-An Hsu; Ming-Sheng Teng; Jeng-Feng Lin; Yu-Chen Sun; Yu-Lin Ko
Journal:  BMC Med Genet       Date:  2013-03-04       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.